Tapewire

Nasdaq · USD

AKTX

Akari Therapeutics Plc

Export transactions ↓
Tapewire entity
7692
SEC CIK
0001541157
Parsed reports
81

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 01, 2025 Filed Nov 4, 2025 22:00 UTC
Farag Kameel D.Interim CFO
GrantAmerican Depositary Shares representing Ordinary Shares 32,000 $0.75 $24,000.00
Disclosure

SEC source: 0001493152-25-020753 · ownership.xml · nonDerivative · entry 1

Farag Kameel D. · CIK 0002093620 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,000

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer

F2 · shares: These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on January 1, 2026.

Read SEC document
October 22, 2025 Filed Oct 24, 2025 13:18 UTC
Farag Kameel D.Interim CFO
GrantAmerican Depositary Shares representing Ordinary Shares 6,277 $0.74 $4,644.98
Disclosure

SEC source: 0001493152-25-019194 · ownership.xml · nonDerivative · entry 1

Farag Kameel D. · CIK 0002093620 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,277

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer

F2 · shares: These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on October 31, 2025.

Read SEC document
August 25, 2025 Filed Aug 29, 2025 20:55 UTC
Gaslightwala AbizerDirector · CEO
PurchaseAmerican Depositary Shares representing Ordinary Shares 3,000 $0.90 $2,700.00
Disclosure

SEC source: 0001641172-25-026025 · ownership.xml · nonDerivative · entry 3

Gaslightwala Abizer · CIK 0002049375 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 298,574

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.89 to $0.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.

Read SEC document
August 22, 2025 Filed Aug 29, 2025 20:55 UTC
Gaslightwala AbizerDirector · CEO
PurchaseAmerican Depositary Shares representing Ordinary Shares 8,000 $0.93 $7,440.00
Disclosure

SEC source: 0001641172-25-026025 · ownership.xml · nonDerivative · entry 2

Gaslightwala Abizer · CIK 0002049375 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,574

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.92 to $0.93, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.

Read SEC document
August 21, 2025 Filed Aug 29, 2025 20:55 UTC
Gaslightwala AbizerDirector · CEO
PurchaseAmerican Depositary Shares representing Ordinary Shares 10,000 $0.94 $9,400.00
Disclosure

SEC source: 0001641172-25-026025 · ownership.xml · nonDerivative · entry 1

Gaslightwala Abizer · CIK 0002049375 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,574

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.94, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.

Read SEC document
June 24, 2025 Filed Jun 25, 2025 20:30 UTC
Gaslightwala AbizerDirector · President & CEO
PurchaseAmerican Depositary Shares representing Ordinary Shares 5,203 $1.16 $6,035.48
Disclosure

SEC source: 0000950170-25-089976 · ownership.xml · nonDerivative · entry 2

Gaslightwala Abizer · CIK 0002049375 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,574

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 20:30 UTC
Gaslightwala AbizerDirector · President & CEO
PurchaseAmerican Depositary Shares representing Ordinary Shares 943 $1.15 $1,084.45
Disclosure

SEC source: 0000950170-25-089976 · ownership.xml · nonDerivative · entry 1

Gaslightwala Abizer · CIK 0002049375 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,371

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
June 20, 2025 Filed Jun 24, 2025 20:30 UTC
Gaslightwala AbizerDirector · President & CEO
PurchaseAmerican Depositary Shares representing Ordinary Shares 10,000 $1.20 $12,000.00
Disclosure

SEC source: 0000950170-25-089462 · ownership.xml · nonDerivative · entry 1

Gaslightwala Abizer · CIK 0002049375 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,428

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
June 17, 2025 Filed Jun 20, 2025 20:05 UTC
Gaslightwala AbizerDirector · President & CEO
PurchaseAmerican Depositary Shares representing Ordinary Shares 15,000 $1.20 $18,000.00
Disclosure

SEC source: 0000950170-25-088490 · ownership.xml · nonDerivative · entry 1

Gaslightwala Abizer · CIK 0002049375 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,428

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 21:00 UTC
Gaslightwala AbizerDirector · CEO
GrantAmerican Depositary Shares representing Ordinary Shares 25,000 $1.19 $29,750.00
Disclosure

SEC source: 0000950170-25-086829 · ownership.xml · nonDerivative · entry 2

Gaslightwala Abizer · CIK 0002049375 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,428

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F3 · kind: On June 13, 2025, the Reporting Person acquired 10,000 ADS at an average price of $1.19 per ADS.

F3 · price: On June 13, 2025, the Reporting Person acquired 10,000 ADS at an average price of $1.19 per ADS.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 21:00 UTC
Gaslightwala AbizerDirector · CEO
GrantAmerican Depositary Shares representing Ordinary Shares 20,000 $1.23 $24,600.00
Disclosure

SEC source: 0000950170-25-086829 · ownership.xml · nonDerivative · entry 1

Gaslightwala Abizer · CIK 0002049375 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 221,428

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · kind: On June 12, 2025, the Reporting Person acquired 20,000 ADS at an average price of $1.23 per ADS.

F2 · price: On June 12, 2025, the Reporting Person acquired 20,000 ADS at an average price of $1.23 per ADS.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:30 UTC
Gaslightwala AbizerDirector · CEO
GrantAmerican Depositary Shares representing Ordinary Shares 20,000 $1.27 $25,400.00
Disclosure

SEC source: 0000950170-25-085472 · ownership.xml · nonDerivative · entry 1

Gaslightwala Abizer · CIK 0002049375 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,428

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · kind: On June 10, 2025, the Reporting Person acquired 20,000 ADS at an average price of $1.27 per ADS.

F2 · price: On June 10, 2025, the Reporting Person acquired 20,000 ADS at an average price of $1.27 per ADS.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 225,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043935 · ownership.xml · derivative · entry 7

Patel Sandip I · CIK 0001843601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares

Expires 2035-03-20

F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043935 · ownership.xml · derivative · entry 6

Patel Sandip I · CIK 0001843601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares

Expires 2035-03-20

F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 600,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043933 · ownership.xml · derivative · entry 3

Gaslightwala Abizer · CIK 0002049375 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: American Depositary Shares representing Ordinary Shares · 600,000 shares

Expires 2035-03-20

F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock options shall vest upon achievement of at least one of the following performance criteria: either (a) closing of a qualified financing of at least $15,000,000 in gross proceeds on or before December 31, 2025, or (b) closing of an antibody drug conjugate ("ADC") focused license transaction, with a minimum upfront payment of $10,000,000 on or before December 31, 2025. If neither of these criteria are met by December 31, 2025 the performance-based option will expire. The stock option award is subject to continued service with the Issuer.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 1,100,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043933 · ownership.xml · derivative · entry 2

Gaslightwala Abizer · CIK 0002049375 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,100,000

Underlying: American Depositary Shares representing Ordinary Shares · 1,100,000 shares

Expires 2035-03-20

F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 17:00 UTC
Huh HoyoungDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 225,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043936 · ownership.xml · derivative · entry 4

Huh Hoyoung · CIK 0001401267 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares

Expires 2035-03-20

F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 17:00 UTC
Huh HoyoungDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043936 · ownership.xml · derivative · entry 3

Huh Hoyoung · CIK 0001401267 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares

Expires 2035-03-20

F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC
Neal James RDirector
GrantStock Option (Right to Buy) · Derivative 225,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043940 · ownership.xml · derivative · entry 3

Neal James R · CIK 0001600865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares

Expires 2035-03-20

F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC
Neal James RDirector
GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043940 · ownership.xml · derivative · entry 2

Neal James R · CIK 0001600865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares

Expires 2035-03-20

F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 225,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043939 · ownership.xml · derivative · entry 3

Bazemore Robert B · CIK 0001620152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares

Expires 2035-03-20

F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043939 · ownership.xml · derivative · entry 2

Bazemore Robert B · CIK 0001620152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares

Expires 2035-03-20

F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 225,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043938 · ownership.xml · derivative · entry 4

Patel Samir Rashmikant · CIK 0001702447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares

Expires 2035-03-20

F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043938 · ownership.xml · derivative · entry 3

Patel Samir Rashmikant · CIK 0001702447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares

Expires 2035-03-20

F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 225,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043937 · ownership.xml · derivative · entry 5

Prudo-Chlebosz Raymond · CIK 0001653262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares

Expires 2035-03-20

F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043937 · ownership.xml · derivative · entry 4

Prudo-Chlebosz Raymond · CIK 0001653262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares

Expires 2035-03-20

F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043934 · ownership.xml · derivative · entry 3

Hombeck Torsten · CIK 0001983682 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: American Depositary Shares representing Ordinary Shares · 200,000 shares

Expires 2035-03-20

F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock options shall vest upon achievement of at least one of the following performance criteria: either (a) closing of a qualified financing of at least $15,000,000 in gross proceeds on or before December 31, 2025, or (b) closing of an antibody drug conjugate ("ADC") focused license transaction, with a minimum upfront payment of $10,000,000 on or before December 31, 2025. If neither of these criteria are met by December 31, 2025 the performance-based option will expire. The stock option award is subject to continued service with the Issuer.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:00 UTC GrantStock Option (Right to Buy) · Derivative 300,000 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0000950170-25-043934 · ownership.xml · derivative · entry 2

Hombeck Torsten · CIK 0001983682 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: American Depositary Shares representing Ordinary Shares · 300,000 shares

Expires 2035-03-20

F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantSeries B Warrants (Right to Buy) · Derivative 133,928 $1.12 Strike: $0.87 $149,999.36
Disclosure

SEC source: 0000950170-25-036483 · ownership.xml · derivative · entry 3

Gaslightwala Abizer · CIK 0002049375 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,928

Underlying: American Depositary Shares representing Ordinary Shares · 133,928 shares

Expires 2030-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantSeries A Warrants (Right to Buy) · Derivative 133,928 $1.12 Strike: $0.87 $149,999.36
Disclosure

SEC source: 0000950170-25-036483 · ownership.xml · derivative · entry 2

Gaslightwala Abizer · CIK 0002049375 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,928

Underlying: American Depositary Shares representing Ordinary Shares · 133,928 shares

Expires 2026-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantAmerican Depositary Shares representing Ordinary Shares 133,928 $1.12 $149,999.36
Disclosure

SEC source: 0000950170-25-036483 · ownership.xml · nonDerivative · entry 1

Gaslightwala Abizer · CIK 0002049375 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,428

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · kind: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 17:00 UTC
Huh HoyoungDirector · 10% owner
GrantSeries B Warrants (Right to Buy) · Derivative 892,857 $1.12 Strike: $0.87 $999,999.84
Disclosure

SEC source: 0000950170-25-036488 · ownership.xml · derivative · entry 4

Huh Hoyoung · CIK 0001401267 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 892,857

Underlying: American Depositary Shares representing Ordinary Shares · 892,857 shares

Expires 2030-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 17:00 UTC
Huh HoyoungDirector · 10% owner
GrantSeries A Warrants (Right to Buy) · Derivative 892,857 $1.12 Strike: $0.87 $999,999.84
Disclosure

SEC source: 0000950170-25-036488 · ownership.xml · derivative · entry 3

Huh Hoyoung · CIK 0001401267 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 892,857

Underlying: American Depositary Shares representing Ordinary Shares · 892,857 shares

Expires 2026-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 17:00 UTC
Huh HoyoungDirector · 10% owner
GrantAmerican Depositary Shares representing Ordinary Shares 892,857 $1.12 $999,999.84
Disclosure

SEC source: 0000950170-25-036488 · ownership.xml · nonDerivative · entry 1

Huh Hoyoung · CIK 0001401267 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,695,854

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · kind: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantSeries B Warrants (Right to Buy) · Derivative 446,428 $1.12 Strike: $0.87 $499,999.36
Disclosure

SEC source: 0000950170-25-036487 · ownership.xml · derivative · entry 5

Prudo-Chlebosz Raymond · CIK 0001653262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 446,428

Underlying: American Depositary Shares representing Ordinary Shares · 446,428 shares

Expires 2030-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantSeries A Warrants (Right to Buy) · Derivative 446,428 $1.12 Strike: $0.87 $499,999.36
Disclosure

SEC source: 0000950170-25-036487 · ownership.xml · derivative · entry 4

Prudo-Chlebosz Raymond · CIK 0001653262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 446,428

Underlying: American Depositary Shares representing Ordinary Shares · 446,428 shares

Expires 2026-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantAmerican Depositary Shares representing Ordinary Shares 446,428 $1.12 $499,999.36
Disclosure

SEC source: 0000950170-25-036487 · ownership.xml · nonDerivative · entry 1

Prudo-Chlebosz Raymond · CIK 0001653262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,484,990

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · kind: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantSeries B Warrants (Right to Buy) · Derivative 406,250 $1.12 Strike: $0.87 $455,000.00
Disclosure

SEC source: 0000950170-25-036486 · ownership.xml · derivative · entry 4

Patel Samir Rashmikant · CIK 0001702447 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · PranaBio Investments LLC

Disclosed balance after: 406,250

Underlying: American Depositary Shares representing Ordinary Shares · 406,250 shares

Expires 2030-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantSeries A Warrants (Right to Buy) · Derivative 406,250 $1.12 Strike: $0.87 $455,000.00
Disclosure

SEC source: 0000950170-25-036486 · ownership.xml · derivative · entry 3

Patel Samir Rashmikant · CIK 0001702447 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · PranaBio Investments LLC

Disclosed balance after: 406,250

Underlying: American Depositary Shares representing Ordinary Shares · 406,250 shares

Expires 2026-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantAmerican Depositary Shares representing Ordinary Shares 406,250 $1.12 $455,000.00
Disclosure

SEC source: 0000950170-25-036486 · ownership.xml · nonDerivative · entry 1

Patel Samir Rashmikant · CIK 0001702447 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · PranaBio Investments LLC

Disclosed balance after: 3,031,005

F1 · security: Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · kind: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC
Neal James RDirector
GrantSeries B Warrants (Right to Buy) · Derivative 4,464 $1.12 Strike: $0.87 $4,999.68
Disclosure

SEC source: 0000950170-25-036485 · ownership.xml · derivative · entry 3

Neal James R · CIK 0001600865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,464

Underlying: American Depositary Shares representing Ordinary Shares · 4,464 shares

Expires 2030-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC
Neal James RDirector
GrantSeries A Warrants (Right to Buy) · Derivative 4,464 $1.12 Strike: $0.87 $4,999.68
Disclosure

SEC source: 0000950170-25-036485 · ownership.xml · derivative · entry 2

Neal James R · CIK 0001600865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,464

Underlying: American Depositary Shares representing Ordinary Shares · 4,464 shares

Expires 2026-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC
Neal James RDirector
GrantAmerican Depositary Shares representing Ordinary Shares 4,464 $1.12 $4,999.68
Disclosure

SEC source: 0000950170-25-036485 · ownership.xml · nonDerivative · entry 1

Neal James R · CIK 0001600865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,271

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · kind: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantSeries B Warrants (Right to Buy) · Derivative 44,642 $1.12 Strike: $0.87 $49,999.04
Disclosure

SEC source: 0000950170-25-036482 · ownership.xml · derivative · entry 3

Bazemore Robert B · CIK 0001620152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,642

Underlying: American Depositary Shares representing Ordinary Shares · 44,642 shares

Expires 2030-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantSeries A Warrants (Right to Buy) · Derivative 44,642 $1.12 Strike: $0.87 $49,999.04
Disclosure

SEC source: 0000950170-25-036482 · ownership.xml · derivative · entry 2

Bazemore Robert B · CIK 0001620152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,642

Underlying: American Depositary Shares representing Ordinary Shares · 44,642 shares

Expires 2026-03-06

F2 · kind: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:00 UTC GrantAmerican Depositary Shares representing Ordinary Shares 44,642 $1.12 $49,999.04
Disclosure

SEC source: 0000950170-25-036482 · ownership.xml · nonDerivative · entry 1

Bazemore Robert B · CIK 0001620152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,642

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · kind: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

Read SEC document
March 06, 2025 Filed Apr 29, 2025 21:00 UTC GrantSeries B Warrants (Right to Buy) · Derivative 44,642 $1.12 Strike: $0.87 $49,999.04
Disclosure

SEC source: 0000950170-25-060298 · ownership.xml · derivative · entry 7

Patel Sandip I · CIK 0001843601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,642

Underlying: American Depositary Shares representing Ordinary Shares · 44,642 shares

Expires 2030-03-06

F2 · kind: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Apr 29, 2025 21:00 UTC GrantSeries A Warrants (Right to Buy) · Derivative 44,642 $1.12 Strike: $0.87 $49,999.04
Disclosure

SEC source: 0000950170-25-060298 · ownership.xml · derivative · entry 6

Patel Sandip I · CIK 0001843601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,642

Underlying: American Depositary Shares representing Ordinary Shares · 44,642 shares

Expires 2026-03-06

F2 · kind: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

Read SEC document
March 06, 2025 Filed Apr 29, 2025 21:00 UTC GrantAmerican Depositary Shares representing Ordinary Shares 44,642 $1.12 $49,999.04
Disclosure

SEC source: 0000950170-25-060298 · ownership.xml · nonDerivative · entry 1

Patel Sandip I · CIK 0001843601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 496,499

F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · kind: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

F2 · price: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.

Read SEC document
January 10, 2025 Filed Jan 13, 2025 13:05 UTC GrantAmerican Depository Shares representing Ordinary Shares 11,439 $1.22 $13,955.58
Disclosure

SEC source: 0000950170-25-004580 · ownership.xml · nonDerivative · entry 1

Gaslightwala Abizer · CIK 0002049375 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,860

F1 · security: Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.

F2 · kind: On January 10, 2025, the Reporting Person acquired 11,439 ADS at purchase price of $1.22 per ADS.

F2 · price: On January 10, 2025, the Reporting Person acquired 11,439 ADS at purchase price of $1.22 per ADS.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.